Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to assess the accuracy in terms of sensitivity, specificity, negative and positive predicted values of the DL-based algorithm with respect to correct identification of the plaque and associated vulnerability grade.
Data collected in this study will be used for technology development, scientific evaluation, education, and regulatory submissions for future products. This is a pre-market, open label, prospective, non-randomized clinical research study conducted at one site in Italy. The product being researched is the Deep Learning-based (DL) algorithm for non-invasive detection of vulnerable coronary plaque.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Ospedale Di Voghera, Azienda Socio-Sanitaria Territoriale di Pavia
Pavia, Lombardy, Italy
Start Date
January 1, 2025
Primary Completion Date
June 1, 2025
Completion Date
June 1, 2025
Last Updated
January 7, 2025
200
ESTIMATED participants
Deep Learning-based Vulnerable Plaque Detection and Assessment Tool
OTHER
Lead Sponsor
GE Healthcare
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07444957